I am a Transplant Hepatologist at Virginia Commonwealth University. I was an Emerging Liver Scholar in 2020 and received the 2024 Ashwani K. Singal Advanced/Transplant Hepatology Fellow Award for Research in Alcohol-Associated Liver Disease. My research interest is in alcohol associated liver disease (ALD), particularly in the early diagnosis and prevention of ALD.

Michael R. Lucey MD<br>Brief Biography<br>June 29, 2025<br><br>Dr Michael Ronan Lucey was born in Dublin, Ireland, and was educated at Trinity College, Dublin, graduating with the degrees of M.B., B.Ch in 1976. He was awarded an M.D. by thesis in 1985. He completed his internship at the Meath Hospital, Dublin and residency in Internal Medicine at the Federated Dublin Voluntary Hospitals. He undertook a fellowship in Gastroenterology at Saint Bartholomew's Hospital, London and subsequently a fellowship in Liver Diseases in Kings College Hospital, London.

Adam Gehring received his Ph.D. at Case Western Reserve University in Cleveland, Ohio. His training included a Postdoctoral Fellowship in the Institute of Hepatology at University College London and a position of Senior Research Fellow, and subsequently Assistant Principal Investigator, at the Singapore Institute for Clinical Sciences with Antonio Bertoletti. Dr. Gehring moved to Saint Louis University as an Assistant Professor in March 2013 before taking a position at the Toronto Center for Liver Disease in February 2016.<br><br>Dr.

Betsy Read-Connole Ph.D., DIvision of Cancer Biology, National Cancer Institute, NIH<br>Dr. Read-Connole received a B.A. in Biology and Chemistry from Mary Baldwin University, Staunton, VA, a M.S. in Microbiology and a Ph.D. in Molecular and Cell Biology from the University of Maryland, College Park. She held a Cancer Research Training Fellow with the HIV and AIDS Malignancy Branch in the National Cancer Institute (NCI) at the National Institutes of Health (NIH). Dr.

Nneka N. Ufere, MD MSCE is a transplant hepatologist and Assistant Professor of Medicine in the Division of Gastroenterology at Massachusetts General Hospital and Harvard Medical School in Boston, MA. She is a health services and patient-centered outcomes researcher whose work is at the intersection of hepatology, transplant, and palliative care. As a clinical trialist, she develops and tests supportive care interventions aimed at increasing the quality of life, quality of care, and healthcare system empathy for patients with cirrhosis and their families.

Anji Wall is an abdominal transplant surgeon and bioethicist at the Baylor Simmons Transplant Institute in Dallas, TX, where she also serves as the vice chair of research and the medical director of the Baylor Scott and White Transplant Center for Innovation, Science, Policy Research and Ethics (INSPIRE). Her research interests include transplant policy ethics, innovative strategies to expand deceased organ donation, and the ethical challenges with deceased organ donation.

Dr. Ibrahim is a Professor of Pediatrics and Physiology; she is a pediatric transplant hepatologist and a physician scientist. Samar is the Principal Investigator of the NIH-funded lipotoxicity and liver inflammation laboratory at Mayo Clinic. She studies mechanisms of liver injury and inflammation in metabolic dysfunction associated steatohepatitis (MASH) with the goal to identify novel biomarkers and mechanism-based therapeutic targets.

Dr. Emily R. Perito is a Professor of Clinical Pediatrics at UCSF in the Departments of Pediatrics and of Epidemiology and Biostatistics. She is Medical Director of UCSF's multi-disciplinary Pediatric Liver Center. She is Co-Chair of the Starzl Network for Excellence in Pediatric Transplantation and helps lead their efforts to improve the efficacy and reduce the burden of immunosuppression for children after liver transplant.